Partner/Owner

Representative before the EPO

Employment test 201 - 500 employees
Company dna hgf ltd
operating since 1995
1346.52
Headquarter in Leeds and 20 offices
active in Legal Services and IP Consulting

We have observed 5 EP applications Andrew Richard Camenisch has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 06, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12752678

DOPED MULTIWALLED CARBON NANOTUBE FIBERS AND METHODS OF MAKING THE SAME

IPC classification:
C01B 31/02, B82B 3/00
Applicant:
William Marsh Rice University
Agent:
Andrew Richard Camenisch, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP12742728

METHODS AND COMPOSITIONS FOR HIGHLY SPECIFIC CAPTURE AND RELEASE OF BIOLOGICAL MATERIALS

IPC classification:
G01N 33/543, G01N 33/553, C12Q 1/00
Applicant:
Northeastern University
Agent:
Andrew Richard Camenisch, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP12796914

SORPTION AND SEPARATION OF VARIOUS MATERIALS BY GRAPHENE OXIDES

IPC classification:
B01J 20/00
Applicant:
William Marsh Rice University
Agent:
Andrew Richard Camenisch, HGF Limited
Agent:
Hans-Peter Staudt, Staudt IP Law
Agent:
Hans-Peter Staudt, Bittner & Kollegen GbR
Status:
GRANT OF PATENT INTENDED
EP12737015

GRAPHENE-BASED THIN FILMS IN HEAT CIRCUITS AND METHODS OF MAKING THE SAME

IPC classification:
B32B 9/04, B05D 5/12
Applicant:
William Marsh Rice University
Applicant:
Lockheed Martin Corporation
Agent:
Andrew Richard Camenisch, HGF Limited
Status:
APPLICATION WITHDRAWN
EP11845460

NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION

IPC classification:
A61P 31/20, A61P 31/18, A61P 31/12, A61K 38/13, C07K 7/64, A61K 38/00
Agent:
Andrew Richard Camenisch, HGF Limited
Status:
PATENT GRANTED

Please Sign in to use this feature